Chembio diagnostics, Inc.
CEMI
CEMI was delisted on the 27th of April, 2023.
39 hedge funds and large institutions have $37.3M invested in Chembio diagnostics, Inc. in 2019 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 13 increasing their positions, 10 reducing their positions, and 6 closing their positions.
30% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 10
7% less funds holding
Funds holding: 42 → 39 (-3)
12% less capital invested
Capital invested by funds: $42.5M → $37.3M (-$5.2M)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$2.14M |
| 2 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$983K |
| 3 |
PM
Penbrook Management
New York
|
+$829K |
| 4 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
+$592K |
| 5 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
+$263K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$4.54M |
| 2 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$2.24M |
| 3 |
AIP
ARS Investment Partners
New York
|
-$985K |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$832K |
| 5 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
-$169K |
CEMI Hedge Fund Activity: Q1 2019 in Review
39 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Chembio diagnostics, Inc. (CEMI) for Q1 2019, worth a combined $37.3M — down 12% from $42.5M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of CEMI and 4 opened new positions — a net loss of 2 holders — while 10 trimmed existing stakes and 13 added.
The largest buyer was Nantahala Capital Management, adding an estimated $2.14M. The largest seller was Wellington Management Group, exiting entirely with an estimated $4.54M sold.
- 39 institutional investors held Chembio diagnostics, Inc. (CEMI) as of Q1 2019, down from 42 in Q4 2018.
- Funds reported $37.3M of Chembio diagnostics, Inc. stock for Q1 2019, down 12% quarter-over-quarter.
- 4 funds opened new Chembio diagnostics, Inc. positions in Q1 2019 and 6 closed out, a net change of -2 holders.
- The largest Chembio diagnostics, Inc. buyer in Q1 2019 was Nantahala Capital Management, an estimated $2.14M added.
- The largest Chembio diagnostics, Inc. seller in Q1 2019 was Wellington Management Group, an estimated $4.54M sold.
Based on aggregated 13F filings for Q1 2019.